Neurotoxicity secondary to antineoplastic drugs
Authors:
- Steen Werner HansenSHSteen Werner Hansen
- 1 April 1994
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 20 (2) , 191-214
Abstract
No abstract availableThis publication has 133 references indexed in Scilit:
- Transient focal leukoencephalopathy following intraventricular methotrexate and cytarabineChild's Nervous System, 1990
- Cisplatin NeurotoxicityNew England Journal of Medicine, 1990
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsEuropean Journal of Cancer and Clinical Oncology, 1988
- Acute high‐dose methotrexate neurotoxicity in the ratAnnals of Neurology, 1986
- Ototoxicity of low- and moderate-dose cisplatinCancer, 1985
- Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer a phase I-II studyCancer, 1983
- Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administrationEuropean Journal of Cancer and Clinical Oncology, 1983
- Possible enhancement of vincristine neuropathy by VP-16Cancer, 1982
- Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatmentCancer, 1979